Directed differentiation of human embryonic stem cells into parathyroid cells and establishment of parathyroid organoids

Abstract

Differentiation of human embryonic stem cells (hESCs) into human embryonic stem cells-derived parathyroid-like cells (hESC-PT) has clinical significance in providing new therapies for congenital and acquired parathyroid insufficiency conditions. However, a highly reproducible, well-documented method for parathyroid differentiation remains unavailable. By imitating the natural process of parathyroid embryonic development, we proposed a new hypothesis about the in vitro differentiation of parathyroid-like cells. Transcriptome, differentiation marker protein detection and parathyroid hormone (PTH) secretion assays were performed after the completion of differentiation. To optimize the differentiation protocol and further improve the differentiation rate, we designed glial cells missing transcription factor 2 (GCM2) overexpression lentivirus transfection assays and constructed hESCs-derived parathyroid organoids. The new protocol enabled hESCs to differentiate into hESC-PT. HESC-PT cells expressed PTH, GCM2 and CaSR proteins, low extracellular calcium culture could stimulate hESC-PT cells to secrete PTH. hESC-PT cells overexpressing GCM2 protein secreted PTH earlier than their counterpart hESC-PT cells. Compared with the two-dimensional cell culture environment, hESCs-derived parathyroid organoids secreted more PTH. Both GCM2 lentiviral transfection and three-dimensional cultures could make hESC-PT cells functionally close to human parathyroid cells. Our study demonstrated that hESCs could differentiate into hESC-PT in vitro, which paves the road for applying the technology to treat hypoparathyroidism and introduces new approaches in the field of regenerative medicine.

References

[1] KhundmiriSJ, MurrayRD, LedererE. PTH and vitamin D. Compr Physiol. 2016;6:561-601.

[2] BilezikianJP. Hypoparathyroidism. J Clin Endocrinol Metab. 2020;105:1736.

[3] HakamiY, KhanA. Hypoparathyroidism. Front Horm Res. 2019;51:109-126.

[4] WangQ, Xiangli W, ChenX, et al. Primary study of identification of parathyroid gland based on laser-induced breakdown spectroscopy. Biomed Opt Express. 2021;12:1999-2014.

[5] ŞenkalS, Doğan A. Parathyroid cell differentiation from progenitor cells and stem cells: development, molecular mechanism, function, and tissue engineering. Adv Exp Med Biol. 2021;1387:13-24.

[6] OrloffLA, Wiseman SM, BernetVJ, et al. American Thyroid Association statement on postoperative hypoparathyroidism: diagnosis, prevention, and management in adults. Thyroid. 2018;28:830-841.

[7] BrandiML, Bilezikian JP, ShobackD, et al. Management of hypoparathyroidism: summary statement and guidelines. J Clin Endocrinol Metab. 2016;101:2273-2283.

[8] JoletteJ, WilkerCE, SmithSY, et al. Defining a noncarcinogenic dose of recombinant human parathyroid hormone 1-84 in a 2-year study in Fischer 344 rats. Toxicol Pathol. 2006;34:929-940.

[9] MannstadtM, ClarkeBL, VokesT, et al. Efficacy and safety of recombinant human parathyroid hormone (1–84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study. Lancet Diabetes Endocrinol. 2013;1:275-283.

[10] MigliettaF, Palmini G, GiustiF, et al. Hypoparathyroidism: state of the art on cell and tissue therapies. Int J Mol Sci. 2021;22(19):10272.

[11] BinghamEL, ChengSP, Woods IgnatoskiKM, DohertyGM. Differentiation of human embryonic stem cells to a parathyroid-like phenotype. Stem Cells Dev. 2009;18:1071-1080.

[12] Woods IgnatoskiKM, Bingham EL, FromeLK, DohertyGM. Differentiation of precursors into parathyroid-like cells for treatment of hypoparathyroidism. Surgery. 2010;148:1186-1190.

[13] LawtonBR, Martineau C, SosaJA, et al. Differentiation of PTH-expressing cells from human pluripotent stem cells. Endocrinology. 2020;161(10):bqaa141.

[14] PeissigK, CondieBG, ManleyNR. Embryology of the parathyroid glands. Endocrinol Metab Clin North Am. 2018;47:733-742.

[15] Gras-PenaR, DanzlNM, Khosravi-MaharlooeiM, et al. Human stem cell-derived thymic epithelial cells enhance human T-cell development in a xenogeneic thymus. J Allergy Clin Immunol. 2022;149(5):1755-1771.

[16] OtsukaR, WadaH, TsujiH, et al. Efficient generation of thymic epithelium from induced pluripotent stem cells that prolongs allograft survival. Sci Rep. 2020;10:224.

[17] ZhangY, BaileyD, YangP, Kim E, QueJ. The development and stem cells of the esophagus. Development. 2021;148(6):dev193839.

[18] YasuiR, SekineK, YamaguchiK, Furukawa Y, TaniguchiH. Robust parameter design of human induced pluripotent stem cell differentiation protocols defines lineage-specific induction of anterior-posterior gut tube endodermal cells. Stem Cells. 2021;39:429-442.

[19] Shacham-SilverbergV, Wells JM. Generation of esophageal organoids and organotypic raft cultures from human pluripotent stem cells. Methods Cell Biol. 2020;159:1-22.

[20] RaadS, DavidA, QueJ, FaureC. Genetic mouse models and induced pluripotent stem cells for studying tracheal-esophageal separation and esophageal development. Stem Cells Dev. 2020;29:953-966.

[21] LeibelSL, McVicar RN, WinquistAM, NilesWD, SnyderEY. Generation of complete multi-cell type lung organoids from human embryonic and patient-specific induced pluripotent stem cells for infectious disease modeling and therapeutics validation. Curr Protoc Stem Cell Biol. 2020;54:e118.

[22] GreenMD, ChenA, NostroMC, et al. Generation of anterior foregut endoderm from human embryonic and induced pluripotent stem cells. Nat Biotechnol. 2011;29:267-272.

[23] MillerAJ, DyeBR, Ferrer-TorresD, et al. Generation of lung organoids from human pluripotent stem cells in vitro. Nat Protoc. 2019;14:518-540.

[24] TrisnoSL, PhiloKED, McCrackenKW, et al. Esophageal organoids from human pluripotent stem cells delineate Sox2 functions during esophageal specification. Cell Stem Cell. 2018;23:501-515.

[25] LeibelSL, McVicar RN, WinquistAM, SnyderEY. Generation of 3D whole lung organoids from induced pluripotent stem cells for modeling lung developmental biology and disease. J Vis Exp. 2021;170:1-18.

[26] ZhangY, YangY, JiangM, et al. 3D modeling of esophageal development using human PSC-derived basal progenitors reveals a critical role for notch signaling. Cell Stem Cell. 2018;23:516-529.

[27] BainVE, GordonJ, O’NeilJD, RamosI, RichieER, ManleyNR. Tissue-specific roles for sonic hedgehog signaling in establishing thymus and parathyroid organ fate. Development. 2016;143:4027-4037.

[28] BrennanSC, ThiemU, RothS, et al. Calcium sensing receptor signalling in physiology and cancer. Biochim Biophys Acta. 2013;1833:1732-1744.

[29] HannanFM, KallayE, ChangW, Brandi ML, ThakkerRV. The calcium-sensing receptor in physiology and in calcitropic and noncalcitropic diseases. Nat Rev Endocrinol. 2018;15:33-51.

[30] JacobA, VedaieM, RobertsDA, et al. Derivation of self-renewing lung alveolar epithelial type II cells from human pluripotent stem cells. Nat Protoc. 2019;14:3303-3332.

[31] LungovaV, ChenX, WangZ, Kendziorski C, ThibeaultSL. Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure. Nat Commun. 2019;10:4161.

[32] ParentAV, RussHA, KhanIS, et al. Generation of functional thymic epithelium from human embryonic stem cells that supports host T cell development. Cell Stem Cell. 2013;13:219-229.

[33] ChhattaAR, CordesM, HanegraafMAJ, et al. De novo generation of a functional human thymus from induced pluripotent stem cells. J Allergy Clin Immunol. 2019;144:1416-1419.

[34] ClemensG, FlowerKR, HendersonAP, et al. The action of all-trans-retinoic acid (ATRA) and synthetic retinoid analogues (EC19 and EC23) on human pluripotent stem cells differentiation investigated using single cell infrared microspectroscopy. Mol Biosyst. 2013;9:677-692.

[35] ChojnowskiJL, MasudaK, TrauHA, Thomas K, CapecchiM, ManleyNR. Multiple roles for HOXA3 in regulating thymus and parathyroid differentiation and morphogenesis in mouse. Development. 2014;141:3697-3708.

[36] GordonJ. Hox genes in the pharyngeal region: how Hoxa3 controls early embryonic development of the pharyngeal organs. Int J Dev Biol. 2018;62:775-783.

[37] ChojnowskiJL, TrauHA, MasudaK, Manley NR. Temporal and spatial requirements for Hoxa3 in mouse embryonic development. Dev Biol. 2016;415:33-45.

[38] JinS, OJ, StellabotteF, ChoeCP. Foxi1 promotes late-stage pharyngeal pouch morphogenesis through ectodermal Wnt4a activation. Dev Biol. 2018;441:12-18.

[39] EdlundRK, OhyamaT, KantarciH, Riley BB, GrovesAK. Foxi transcription factors promote pharyngeal arch development by regulating formation of FGF signaling centers. Dev Biol. 2014;390:1-13.

[40] Moore-ScottBA, ManleyNR. Differential expression of Sonic hedgehog along the anterior-posterior axis regulates patterning of pharyngeal pouch endoderm and pharyngeal endoderm-derived organs. Dev Biol. 2005;278:323-335.

[41] YamagishiH, MaedaJ, HuT, et al. Tbx1 is regulated by tissue-specific forkhead proteins through a common Sonic hedgehog-responsive enhancer. Genes Dev. 2003;17:269-281.

[42] GargV, Yamagishi C, HuT, KathiriyaIS, Yamagishi H, SrivastavaD. Tbx1, a DiGeorge syndrome candidate gene, is regulated by sonic hedgehog during pharyngeal arch development. Dev Biol. 2001;235:62-73.

[43] GordonJ, PatelSR, MishinaY, Manley NR. Evidence for an early role for BMP4 signaling in thymus and parathyroid morphogenesis. Dev Biol. 2010;339:141-154.

[44] NevesH, DupinE, ParreiraL, Douarin NML. Modulation of Bmp4 signalling in the epithelial-mesenchymal interactions that take place in early thymus and parathyroid development in avian embryos. Dev Biol. 2012;361:208-219.

[45] FigueiredoM, SilvaJC, SantosAS, et al. Notch and Hedgehog in the thymus/parathyroid common primordium: crosstalk in organ formation. Dev Biol. 2016;418:268-282.

[46] PatelSR, GordonJ, MahbubF, Blackburn CC, ManleyNR. Bmp4 and Noggin expression during early thymus and parathyroid organogenesis. Gene Expr Patterns. 2006;6:794-799.

[47] Naveh-ManyT, SilverJ. Transcription factors that determine parathyroid development power PTH expression. Kidney Int. 2018;93:7-9.

[48] HanSI, Tsunekage Y, KataokaK. Gata3 cooperates with Gcm2 and MafB to activate parathyroid hormone gene expression by interacting with SP1. Mol Cell Endocrinol. 2015;411:113-120.

[49] ZouD, Silvius D, DavenportJ, GrifoneR, MaireP, XuP. Patterning of the third pharyngeal pouch into thymus/parathyroid by Six and Eya1. Dev Biol. 2006;293:499-512.

[50] GoltzmanD. Physiology of parathyroid hormone. Endocrinol Metab Clin North Am. 2018;47:743-758.

[51] YamadaT, Tatsumi N, AnrakuA, et al. Gcm2 regulates the maintenance of parathyroid cells in adult mice. PloS One. 2019;14:e0210662.

[52] GordonJ, Bennett AR, BlackburnCC, ManleyNR. Gcm2 and Foxn1 mark early parathyroid-and thymus-specific domains in the developing third pharyngeal pouch. Mech Dev. 2001;103:141-143.

[53] GuntherT, ChenZF, KimJ, et al. Genetic ablation of parathyroid glands reveals another source of parathyroid hormone. Nature. 2000;406:199-203.

[54] OkabeM, GrahamA. The origin of the parathyroid gland. Proc Natl Acad Sci U S A. 2004;101:17716-17719.

[55] ParkYS, KimHS, JinYM, et al. Differentiated tonsil-derived mesenchymal stem cells embedded in Matrigel restore parathyroid cell functions in rats with parathyroidectomy. Biomaterials. 2015;65:140-152.

[56] NoltesME, Sondorp LHJ, KrachtL, et al. Patient-derived parathyroid organoids as a tracer and drug-screening application model. Stem Cell Rep. 2022;17(11):2518-2530.

[57] SalehJ, Mercier B, XiW. Bioengineering methods for organoid systems. Biol Cell. 2021;113:475-491.

[58] DuY, LiangZ, WangS, et al. Human pluripotent stem-cell-derived islets ameliorate diabetes in non-human primates. Nat Med. 2022;28:272-282.

[59] DuZW, ChenH, LiuH, et al. Generation and expansion of highly pure motor neuron progenitors from human pluripotent stem cells. Nat Commun. 2015;6:6626.

RIGHTS & PERMISSIONS

2024 The Authors. Cell Proliferation published by Beijing Institute for Stem Cell and Regenerative Medicine and John Wiley & Sons Ltd.